Company: LNAI
Filing Date: 2025-12-03
Form Type: 424B5
Source: 0001731122-25-001626
Chunk: 29

Company: Lunai Bioworks Inc.
Filing Date: 2025-12-03
Form: 424B5
Chunk 29
---
 calling
us or by writing to us at the following address
and phone number:

If you make
a request for such information in writing or
by telephone, we will provide you, without charge, a copy of any or all of the
information incorporated by reference into this prospectus supplement and
the accompanying prospectus (other than an
exhibit to any filing unless we have specifically
incorporated that exhibit by reference into
the filing). Any such request should be directed to:

<div align='center'>LUNAI BIOWORKS INC.

3400 Cottage Way, Suite G2

#32562, Sacramento, CA 95825

(424) 222-9301</div>

You may also access these documents, free of charge on the SEC’s
website at www.sec.gov. Our website address is www.lunaibioworks.com. Except for any documents
that are incorporated by reference into this prospectus supplement and the accompanying prospectus
that may be accessed from our website, the information
available on or through our website is not part
of this prospectus supplement or the accompanying prospectus.

<div align='center'>S-20

Up to $11,702,826

Common Stock

PROSPECTUS SUPPLEMENT

Lunai Bioworks, Inc.

December 2, 2025</div>

PROSPECTUS

<div align='center'>$200,000,000

Renovaro Inc.

Common Stock

Warrants

Units</div>

We may from time to time, in one
or more offerings at prices and on terms that we will determine at the time of each offering, sell common stock, warrants, or a combination
of these securities, or units, up to a total offering price of $200,000,000.

This prospectus describes the
general manner in which our securities may be offered using this prospectus. Each time we offer and sell securities, we will provide you
with a prospectus supplement that will contain specific information about the terms of that offering. Any prospectus supplement may also
add, update, or change information contained in this prospectus. You should carefully read this prospectus and the applicable prospectus
supplement as well as the documents incorporated or deemed to be incorporated by reference in this prospectus before you purchase any
of the securities offered hereby.

This prospectus may not be used
to offer and sell securities unless accompanied by a prospectus supplement.

The Common Stock is listed on
The Nas